Comparative study of both versions of an immunoassay commercialized for therapeutic drug monitoring of adalimumab.
Fiche du document
Date
19 novembre 2014
Discipline
Type de document
Périmètre
Identifiants
- 10261/107779
- EULAR 2013
Source
Organisation
Licence
open
Sujets proches
Drugs--Monitoring Monitoring, Drug Therapeutic drug monitoringCiter ce document
Francisca Llinares-Tello et al., « Comparative study of both versions of an immunoassay commercialized for therapeutic drug monitoring of adalimumab. », Digital.CSIC (SHS)
